February 2022 – content

Life Sciences

Mesa Labs enters molecular diagnostics markets with acquisition

LI-COR gets investment-firm help for global growth

Neogen’s food safety stake to more than double through business combination

Stilla wins new supporters

Lumicks opens Chinese office to cover APAC markets

Cytek stocks up on cell analysis reagents through acquisition

AMSBIO opens EU office

 

General Laboratory

Pillar array column company bought by instrument giant

Krüss to sell directly in Spain

Ductless fume hood pioneer buys bio-safety cabinet producer

Facility brings together two of Metrohm’s acquisitions

Specs Surface bought by industrial investment firm

IKA continues global expansion with two new subsidiaries

Precision manufacturer expands with UHV specialist

Labviva raises fund and signs strategic partner

 

Process & hand-held instrumentation

Diploma sells CEM business to private equity company

Roper continues business transformation with three divestments

Semicon metrology specialist acquires analytical company

SP Industries joins process automation tooling company

Mirion achieves public listing through reverse merger

Inficon postpones Hapsite launch

 

Financials

Covid-related revenues define Takara Bio’s first fiscal half

Testing demand pushes Enzo Biochem to record results

CMT turnover recovery at HBIO in first half

Twist Bioscience guides for deepening losses on doubling R&D spend

Biopharma drives Mesa Labs’ half-year growth

Cytek eyes profitable 2021 in IPO year

Hitachi HT impacted by declining industrial solutions sales

Quantum technologies remain strong at Toptica while OEM laser sales decline

Recovery at Skyray continues into first half of 2021

Analytical Instrument drive Shimadzu in first half

Olympus SSD recovers led by industrial markets

Healthcare at Nikon turns a profit, while Industrial Metrology disappoints

Last quarter American recovery lifts Emerson’s Automation Solutions

Diploma’s environmental stake halved through disposal

Kromek on course for record full-year despite stunted recovery

Process Technologies slow to recover at Roper

Filtration continues to drive Repligen’s growth

Chemical and pharma chimes in recovery at Yokogawa process control

 

Appointments

 

No Comments

No comments yet.

RSS feed for comments on this post. TrackBack URI

Leave a comment